You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/P7r0xx9TBuXk/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Report Content

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

Thank you for submitting your report

We will investigate and take the appropriate action.

Add to Playlist

Moderna's Clot Shot For Tots Is Around 40 Percent Effective

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 17:27 UTC on April 24th, 2022.

#fda
#eua
#moderna

theDTrain

subscribers

BitChute Advertisement

FDA Sets Bar for COVID-19 Vaccine Approval at 50% Effectiveness
https://archive.ph/HYmns
FDA to Require 50 Percent Efficacy for COVID-19 Vaccines
https://archive.ph/zjwMG
FDA issues COVID-19 vaccine guidance, setting 50% effectiveness threshold
https://archive.ph/mQayk
The FDA's cutoff for Covid-19 vaccine effectiveness is 50 percent. What does that mean?
https://archive.ph/4BHp3
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19
https://clinicaltrials.gov/ct2/show/NCT04470427?term=NCT04470427&draw=2&rank=1
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults
https://clinicaltrials.gov/ct2/show/NCT04816643
Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
https://clinicaltrials.gov/ct2/show/NCT04754594
Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
https://clinicaltrials.gov/ct2/show/NCT05310084
Development and Licensure of Vaccines to Prevent COVID-19
https://www.fda.gov/media/139638/download

Like what you see? Consider supporting independent, unsponsored and unfunded media with a one time donation or a small re-occurring donation through Buy Me A Coffee (https://buymeacoffee.com/thedtrain), Subscribestar (https://www.subscribestar.com/thedtrain), PayPal (paypal.me/thedtrain72) or etransfer ([email protected])
Thank you for your support and God bless

Find theDTrain on these platforms:
Bitchute: https://www.bitchute.com/channel/thedtrain/
Odysee: https://odysee.com/@TheDTrain:a
Rumble: https://rumble.com/user/theRealDTrain
Gab: https://gab.com/thedtrain72
Telegram: https://t.me/theDTrain

LESS